Not available
Quote | Exact Sciences Corporation (NASDAQ:EXAS)
Last: | $46.81 |
---|---|
Change Percent: | -0.55% |
Open: | $47.82 |
Close: | $46.81 |
High: | $48.92 |
Low: | $46.78 |
Volume: | 2,397,771 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Exact Sciences Corporation (NASDAQ:EXAS)
2024-07-12 14:30:06 ET More on Exact Sciences: Exact Sciences: Still No Reason To Own Exact Sciences Corporation (EXAS) Q1 2024 Earnings Call Transcript Exact Sciences initiated at sector outperform at Scotiabank on advanced diagnostics Exact Sciences gains a...
2024-07-11 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Exact Sciences Corporation (NASDAQ:EXAS)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $EXAS News Article - Exact Sciences schedules first quarter 2023 earnings call | whytestocks | investorshangout | 04/10/2023 12:20:49 PM |
znewcar1: $EXAS 24% v10,8M c58.82 f177,684M H60.93 gapNgo to HOD | znewcar1 | investorshangout | 01/09/2023 11:12:13 PM |
whytestocks: $EXAS News Article - Medicare and Insurance Policy Updates in 2023 Will Improve Cancer | whytestocks | investorshangout | 12/20/2022 3:30:56 PM |
$EXAS up big time in the pre-market. I've | OldAIMGuy | investorshub | 12/16/2022 1:37:32 PM |
GH(-34%/AH)reports_results_of Shield ctDNA(liquid biopsy)diagnostic_for co | DewDiligence | investorshub | 12/16/2022 12:06:42 AM |
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-07-11 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-08 08:30:00 ET To say that Exact Sciences (NASDAQ: EXAS) hasn't performed well on the stock market this year would be an understatement. Shares of the cancer-focused biotech are down by 41%. However, the healthcare company still has some fans on Wall Street. Cathie Wood ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2024 financial results after the close of the U.S. financial markets on July 31, 2024. Following the release, company management w...